Synopsys (SNPS) Stock Could Be 18.7% Undervalued After Multiphysics Fusion Launch

Synopsys (SNPS) is back in focus after launching its Multiphysics Fusion solutions, which combine AI-powered design tools, Ansys signoff analysis and NVIDIA GPU acceleration to speed up complex semiconductor design workflows.

See our latest analysis for Synopsys.

Despite the Multiphysics Fusion launch and recent collaborations with Murata and Thea Energy, Synopsys’ short term momentum has softened, with a 30 day share price return down 8.7% and year to date share price return down 5.2%. However, the 5 year total shareholder return of 69.4% points to a much stronger longer term record.

If you are assessing how AI driven design tools could influence other opportunities in your portfolio, it may be worth scanning the market using a screener focused on 49 AI infrastructure stocks

With Synopsys shares down in the short term but still carrying a long term record and trading at a small modelled intrinsic discount, investors face a familiar puzzle: is there genuine value left here or is future growth already in the price?

Most Popular Narrative: 18.7% Undervalued

Synopsys last closed at $455.51, while the most followed narrative anchors fair value at $560.38, implying a meaningful gap that hinges on execution of its transition story.

The acquisition and integration of Ansys positions Synopsys as the global leader in engineering solutions from silicon to systems, dramatically expanding its addressable market into sectors like automotive, industrial, and aerospace. This should drive long-term top-line growth as more sophisticated and complex products (especially AI-powered and smart devices) require robust simulation, analysis, and EDA tools.

Read the complete narrative.

Want to see what sits behind that premium fair value for Synopsys? The narrative leans on faster profit growth, richer margins, and a punchy future earnings multiple. Curious which assumptions really move the model?

Result: Fair Value of $560.38 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Synopsys still carries execution and concentration risks, with China headwinds and heavier Ansys related integration costs, both capable of undermining the current upside narrative.

Find out about the key risks to this Synopsys narrative.

Another View: Synopsys Through a P/E Lens

There is a clear tension between the Synopsys fair value anchored at $560.38 and what the market is paying today. On a P/E basis, the stock trades at 112.8x, well above the US Software industry at 25.5x, peers at 33.4x, and even its own fair ratio of 51.9x. That gap highlights valuation risk if expectations cool. Investors may want to consider whether they are comfortable paying more than double the fair ratio for this growth story.

To see how this pricing compares with detailed earnings assumptions and market comparisons, take a closer look at the valuation breakdown in the See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Reading mixed signals on Synopsys and unsure which side of the story carries more weight? Take a moment to review the full risk and reward balance for yourself by checking the 3 key rewards and 3 important warning signs

Looking for more investment ideas beyond Synopsys?

Do not stop at Synopsys when there are other stocks that could suit your goals. Use targeted screens now so you do not miss a potential fit.

• Zero in on potential mispricings by scanning companies that combine quality with attractive valuations through the 45 high quality undervalued stocks.
• Strengthen your income stream by reviewing companies with robust payouts and yields using the 8 dividend fortresses.
• Dial down risk in your portfolio by focusing on companies with sturdier financial profiles via the 66 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com